Rosuvastatin calcium and process for producing intermediate thereof
US-2024360086-A1 · Oct 31, 2024 · US
US10590446B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10590446-B2 |
| Application number | US-201214362036-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 17, 2012 |
| Priority date | Dec 1, 2011 |
| Publication date | Mar 17, 2020 |
| Grant date | Mar 17, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method for producing highly-concentrated L-amino acid and riboflavin simultaneously, and a microorganism for simultaneously producing L-amino acid and riboflavin. Specifically, the present invention relates to a modified microorganism for producing L-lysine or L-threonine, and riboflavin simultaneously, wherein the microorganism belonging to Corynebacterium sp. capable of producing L-lysine or L-threonine is modified by enhancing the activity of an enzyme family expressed by a rib operon which contains riboflavin biosynthesis gene family. Also, the present invention relates to a method for the simultaneous production of L-lysine or L-threonine, and riboflavin using the modified microorganism, and relates to a formulation or granular formulation, feed, and feed additive, containing L-lysine or L-threonine, and riboflavin produced from a culture medium of the modified microorganism.
Opening claim text (preview).
The invention claimed is: 1. A modified Corynebacterium glutamicum microorganism for simultaneously producing L-lysine or L-threonine, and riboflavin, wherein said modified Corynebacterium glutamicum microorganism has enhanced expression of a riboflavin (rib) operon as compared to the expression of a rib operon in a corresponding wild-type Corynebacterium glutamicum microorganism, wherein the rib operon comprises genes encoding riboflavin biosynthesis enzymes, and wherein the expression of the rib operon in said modified Corynebacterium glutamicum microorganism is enhanced by increasing intracellular copy number of the genes of the rib operon, replacing the native promoter of the rib operon with a stronger promoter, and a combination thereof, wherein said modified Corynebacterium glutamicum microorganism has increased L-lysine or L-threonine-producing ability as compared to a corresponding wild-type Corynebacterium glutamicum microorganism, and wherein the concentration of riboflavin produced by said modified Corynebacterium glutamicum microorganism is increased by 56 to 73-fold as compared to the concentration of riboflavin produced by a corresponding wild-type Corynebacterium glutamicum microorganism under the same conditions, while maintaining the increased production of L-lysine or L-threonine as compared to a corresponding wild-type Corynebacterium glutamicum microorganism. 2. The microorganism according to claim 1 , wherein the expression of the rib operon in said modified Corynebacterium glutamicum microorganism is enhanced by replacing the native promoter of the rib operon with a stronger promoter. 3. The microorganism according to claim 2 , wherein the stronger promoter comprises the nucleotide sequence of SEQ ID NO: 5 or 6. 4. The microorganism according to claim 1 , wherein the modified Corynebacterium glutamicum microorganism is the microorganism deposited with Korean Culture Center of Microorganisms (KCCM) under accession No. KCCM11220P, KCCM11221P or KCCM11223P. 5. A method for producing L-lysine or L-threonine, and riboflavin, comprising: a) culturing the modified Corynebacterium glutamicum microorganism of claim 1 in a culture medium; and b) producing L-lysine or L-threonine, and riboflavin by a fermentation process. 6. The method according to claim 5 , which further comprises granulating the fermented culture medium comprising L-lysine or L-threonine, and riboflavin. 7. The method according to claim 5 , which further comprises removing a bacterial sludge from the fermented culture medium comprising L-lysine or L-threonine, and riboflavin.
containing a six-membered hetero ring · CPC title
Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin · CPC title
Lysine; Diaminopimelic acid; Threonine; Valine · CPC title
Bacteria; Culture media therefor · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.